Browse Pet Safety Reports
8,562 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 8,562 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product — widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 8,562 FDA veterinary adverse event reports.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| May 13, 2017 | Cat | Domestic Shorthair | Fluralaner Spot-On Solution | Skin scab; Abnormal cytology; Generalised itching; Miliary dermatitis; Hair l... | Ongoing |
| May 12, 2017 | Dog | Mixed (Dog) | Oclacitinib Maleate | Dermatitis; Abnormal cytology; Pain NOS; Scar; Unable to stand; Furunculosis;... | Ongoing |
| May 12, 2017 | Dog | Bichon Frise | Rabacfosadine Succinate | Skin ulcer; Dermatitis; Dermal thickening; Pruritus | Ongoing |
| May 11, 2017 | Dog | Retriever - Golden | Fluralaner Chew Tablets | Hot spot (pyotraumatic dermatitis) | Ongoing |
| May 11, 2017 | Dog | Akita | Afoxolaner 68 Mg Chewable Tablets | Pruritus; Reddening of the skin; Dermatitis; Hypersalivation; Fever | Recovered/Normal |
| May 11, 2017 | Dog | Terrier - Yorkshire | Afoxolaner 11.3 Mg Chewable Tablets | Tremor; Fever; Apathy; Anorexia; Moist dermatitis; Liver disorder NOS; Pain N... | Recovered/Normal |
| May 10, 2017 | Dog | Dachshund - Standard Long-h... | Trilostane | Electrolyte disorder; Hyperkalaemia; Low sodium-potassium ratio (Na:K ratio);... | Outcome Unknown |
| May 6, 2017 | Dog | Mountain Dog - Bernese | Fluralaner Chew Tablets | Pruritus; Skin scab; Behavioural disorder NOS; Lethargy (see also Central ner... | Ongoing |
| May 5, 2017 | Dog | Basenji, Crossbred Canine/dog | Ivermectin; Pyrantel | Blindness; Hot spot (pyotraumatic dermatitis); Other ear disorder NOS; Ear ca... | Recovered with Sequela |
| May 5, 2017 | Dog | Crossbred Canine/dog, Basen... | Fluralaner Chew Tablets | Blindness; Eye disorder NOS (for photophobia see 'neurological'); Bumping int... | Euthanized |
| May 5, 2017 | Dog | Bulldog | Moxidectin | Injection site ulcer; Erythema (for urticaria see Immune SOC); Injection site... | Ongoing |
| May 5, 2017 | Dog | Deutsche Dogge, Great Dane | Oclacitinib Maleate | Pododermatitis | Ongoing |
| May 2, 2017 | Dog | Mountain Dog - Bernese | Rabacfosadine Succinate | Diarrhoea; Elevated liver enzymes; Elevated gamma-glutamyl transferase (GGT);... | Outcome Unknown |
| May 1, 2017 | Dog | Mountain Dog - Bernese | Polysulfated Glycosaminoglycan | Hot spot (pyotraumatic dermatitis) | Outcome Unknown |
| May 1, 2017 | Cat | Siamese, Cat (unknown) | Spinosad | Lethargy (see also Central nervous system depression in 'Neurological'); Exco... | Ongoing |
| May 1, 2017 | Dog | Terrier - American Stafford... | Spinosad; Milbemycin Oxime | Allergic dermatitis; Lack of efficacy (flea) | Ongoing |
| May 1, 2017 | Dog | Bichon Frise | Levothyroxine | Elevated liver enzymes; Pruritus; Conjunctivitis; Hot spot (pyotraumatic derm... | Outcome Unknown |
| Apr 29, 2017 | Dog | Spaniel - Cocker American | Rabacfosadine Succinate | Skin lesion NOS; Lethargy (see also Central nervous system depression in 'Neu... | Outcome Unknown |
| Apr 28, 2017 | Dog | Terrier - Boston | Oclacitinib Maleate | Fever; Pododermatitis; Neutrophilia; Lymphopenia | Ongoing |
| Apr 27, 2017 | Dog | Crossbred Canine/dog, Lhasa... | Fluralaner Chew Tablets | Scratching; Skin scab; Dermatitis; Localised hair loss; Licking | Recovered/Normal |
| Apr 27, 2017 | Dog | Dachshund (unspecified) | Afoxolaner | Pruritus; Hives (see also 'Skin'); Facial swelling (see also 'Skin'); Dermatitis | Outcome Unknown |
| Apr 27, 2017 | Dog | Chihuahua | Imidacloprid; Moxidectin | Pruritus; Alopecia; Allergic dermatitis; Localised hair loss; Lack of efficac... | Outcome Unknown |
| Apr 25, 2017 | Dog | Terrier (unspecified), Dog ... | Spinosad | Otitis externa; Pododermatitis; Ulcerative dermatitis; Hot spot (pyotraumatic... | Ongoing |
| Apr 24, 2017 | Human | Unknown | Fluralaner Spot-On Solution | Dermatitis; Itchy skin; Rash | Recovered/Normal |
| Apr 24, 2017 | Dog | Retriever - Golden | Sarolaner | Pruritus; Hot spot (pyotraumatic dermatitis) | Recovered/Normal |
| Apr 24, 2017 | Dog | Saint Bernard Dog | Fluralaner Chew Tablets | Pruritus; Moist dermatitis; Petit mal epilepsy; Shaking; Ataxia; Falling; Sta... | Outcome Unknown |
| Apr 21, 2017 | Dog | Retriever - Labrador, Austr... | Afoxolaner 136 Mg Chewable Tablets | Skin swelling; Dermatitis; Conjunctivitis; Blepharitis | Outcome Unknown |
| Apr 19, 2017 | Cat | Domestic Shorthair | Itraconazole | Found dead; Weight loss; NT - hypertrophic dilated cardiomyopathy; Dermatitis... | Died |
| Apr 18, 2017 | Dog | Dachshund - Standard Smooth... | Trilostane | Skin lesion NOS; Blistering (see also Application site SOC); Pustular skin er... | Outcome Unknown |
| Apr 18, 2017 | Dog | Crossbred Canine/dog | Fluralaner Chew Tablets | Emesis (multiple); Lethargy (see also Central nervous system depression in 'N... | Euthanized |
| Apr 17, 2017 | Dog | Chihuahua | Imidacloprid; Moxidectin | Pruritus; Hot spot (pyotraumatic dermatitis); Lack of efficacy (ectoparasite)... | Outcome Unknown |
| Apr 17, 2017 | Dog | Hound - Basset | Fluralaner Chew Tablets | Scratching; Hot spot (pyotraumatic dermatitis) | Recovered/Normal |
| Apr 17, 2017 | Dog | Hound - Basset | Fluralaner Chew Tablets | Scratching; Hot spot (pyotraumatic dermatitis) | Recovered/Normal |
| Apr 17, 2017 | Dog | Mastiff, Dog (unknown) | Oclacitinib Maleate | Otitis NOS; Dermatitis; Skin lump; Neoplasia NOS; Abnormal cytology; Hypothyr... | Ongoing |
| Apr 15, 2017 | Dog | Coonhound - Redbone | Cefpodoxime Proxetil | Pododermatitis; Furunculosis; Enlarged lymph nodes (generalised); Elevated al... | Ongoing |
| Apr 14, 2017 | Dog | Bulldog | Afoxolaner 136 Mg Chewable Tablets | Localised rash; Localised itching; Hot spot (pyotraumatic dermatitis) | Outcome Unknown |
| Apr 12, 2017 | Dog | Great Pyrenees | Spinosad; Milbemycin Oxime | Rash; Hot spot (pyotraumatic dermatitis); Diarrhoea; Itching | Outcome Unknown |
| Apr 12, 2017 | Dog | Pit Bull | Spinosad | Vomiting; Dermatitis | Recovered/Normal |
| Apr 11, 2017 | Dog | Shepherd Dog - German | Oclacitinib Maleate | Pododermatitis; Erythema (for urticaria see Immune SOC); Otitis externa; Alop... | Ongoing |
| Apr 11, 2017 | Dog | Spaniel (unspecified), Pood... | Prednisolone; Trimeprazine Tartrate | Lack of efficacy - NOS; Localised hair loss; Bloodshot eye; Reverse sneezing;... | Ongoing |
| Apr 11, 2017 | Dog | Pekingese, Pug | Spinosad | Lethargy (see also Central nervous system depression in 'Neurological'); Hype... | Outcome Unknown |
| Apr 9, 2017 | Dog | Shepherd Dog - German, Dog ... | Spinosad; Milbemycin Oxime | Not eating; Vomiting; Lethargy (see also Central nervous system depression in... | Ongoing |
| Apr 8, 2017 | Dog | Spaniel - Cocker American, ... | Afoxolaner 68 Mg Chewable Tablets | Lethargy (see also Central nervous system depression in 'Neurological'); Hot ... | Outcome Unknown |
| Apr 6, 2017 | Dog | Bulldog | Oclacitinib Maleate | Keratoconjunctivitis sicca; Moist dermatitis; Skin inflammation NOS; Fever; E... | Ongoing |
| Apr 3, 2017 | Dog | Crossbred Canine/dog | Oclacitinib Maleate | Listless; Decreased appetite; Urticaria; Erythema (for urticaria see Immune S... | Ongoing |
| Apr 2, 2017 | Dog | Mixed (Dog) | Oclacitinib Maleate | Uncomfortable; Skin lesion NOS; Erythema (for urticaria see Immune SOC); Pust... | Euthanized |
| Apr 2, 2017 | Dog | Retriever - Labrador | Afoxolaner | Pruritus; Hot spot (pyotraumatic dermatitis) | Recovered/Normal |
| Apr 1, 2017 | Dog | Retriever - Golden | Afoxolaner 136 Mg Chewable Tablets | Scratching; Hot spot (pyotraumatic dermatitis); Erythema (for urticaria see I... | Outcome Unknown |
| Apr 1, 2017 | Dog | Retriever - Labrador | Afoxolaner | Anxiety; Hyperthermia; Panting; Spasm; Vomiting; Itching; Hot spot (pyotrauma... | Outcome Unknown |
| Apr 1, 2017 | Dog | Terrier - Yorkshire | Oclacitinib Maleate | Dermatitis; Diarrhoea; Other abnormal test result NOS; Anaemia NOS; Thrombocy... | Ongoing |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe — difficulty breathing, seizures, collapse, or severe swelling — seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.